Loading

Please wait...

Rifamate

Generic Name: isoniazid and rifampin (eye so NYE a zid and RIF am pin)
Brand Name: IsonaRif, Rifamate
Physician reviewed Rifamate patient information - includes Rifamate description, dosage and directions.
  • Prescription Settings

Prices and coupons of Rifamate

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code


Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Rifamate are antibiotics that fight bacteria. Rifamate is a combination medicine used to treat tuberculosis (TB). Rifamate may also be used for purposes not listed in this medication guide. You should not use Rifamate if you have active liver disease (including hepatitis or cirrhosis), or a history of liver problems caused by taking isoniazid. Serious and sometimes fatal liver problems may occur during treatment with Rifamate or after you stop taking this medication, even months after stopping. The risk of liver problems is highest in adults between the ages of 35 and 65. Your liver function may need to be checked every month while you are taking Rifamate. Learn more

Rifamate Side Effects

Rifamate Side Effects

Note: This document contains side effect information about isoniazid / rifampin. Some of the dosage forms listed on this page may not apply to the brand name Rifamate.

For the Consumer

Applies to isoniazid/rifampin: oral capsule

Warning

Oral route (Capsule)

Severe and sometimes fatal hepatitis has been reported with isoniazid therapy and may occur even after many months of treatment. The risk for hepatitis generally increases with advancing age and alcohol use. Monthly clinical evaluation and liver function tests should be performed. Instruct patients to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

Along with its needed effects, isoniazid / rifampin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking isoniazid / rifampin:

More common

  • Clumsiness or unsteadiness
  • dark urine
  • loss of appetite
  • nausea and vomiting
  • numbness, tingling, burning, or pain in hands and feet
  • unusual tiredness or weakness
  • yellow eyes or skin

Less common

  • Chills
  • difficult breathing
  • dizziness
  • fever
  • headache
  • itching
  • muscle and bone pain
  • shivering
  • skin rash and redness

Rare

  • Bloody or cloudy urine
  • blurred vision or loss of vision, with or without eye pain
  • convulsions (seizures)
  • depression
  • greatly decreased frequency of urination or amount of urine
  • mood or mental changes
  • sore throat
  • unusual bleeding or bruising

Some side effects of isoniazid / rifampin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Diarrhea
  • stomach pain or upset

Less common

  • Sore mouth or tongue

This medicine commonly causes reddish-orange to reddish-brown discoloration of urine, stool, saliva, sputum, sweat, and tears. This side effect does not usually require medical attention.

Dark urine and yellowing of the eyes or skin (signs of liver problems) are more likely to occur in patients 50 years of age and older.

For Healthcare Professionals

Applies to isoniazid / rifampin: oral capsule

General

Doses greater than 600 mg of rifampin given once or twice weekly have resulted in a higher incidence of adverse reactions, including the "flu syndrome" (fever, chills, malaise); hematopoietic reactions (leukopenia, thrombocytopenia, acute hemolytic anemia); shortness of breath; shock; anaphylaxis; renal failure; and cutaneous, gastrointestinal, and hepatic reactions.

Cardiovascular

Frequency not reported: Vasculitis

Rifampin:

Frequency not reported: Flushing, decreased blood pressure

Dermatologic

Frequency not reported: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, Stevens-Johnson syndrome, Toxic Epidermal Necrolysis (TEN), rash

Isoniazid:

Frequency not reported: Acne, exfoliative dermatitis, pemphigus

Rifampin:

Frequency not reported: Erythema multiforme, skin reaction, pruritus, pruritic rash, urticaria, allergic dermatitis, pemphigoid, sweat discoloration, cutaneous reactions

Endocrine

Isoniazid:

Frequency not reported: Gynecomastia, hyperglycemia

Rifampin:

Rare (less than 0.1%): Adrenal insufficiency

Frequency not reported: Menstrual disorder/disturbances

Gastrointestinal

Frequency not reported: Nausea, vomiting, epigastric distress, diarrhea

Isoniazid:

Frequency not reported: Constipation, dry mouth, pancreatitis

Rifampin:

Frequency not reported: Gastrointestinal disorder, abdominal discomfort, heartburn, flatulence, cramps, pseudomembranous colitis, sore mouth, sore tongue

Hematologic

Frequency not reported: Thrombocytopenia, eosinophilia, agranulocytosis, hemolytic anemia

Isoniazid:

Frequency not reported: Anemia, aplastic anemia, lymphadenopathy

Rifampin:

Uncommon (0.1% to 1%): Leukopenia

Rare (less than 0.1%): Disseminated intravascular coagulation

Frequency not reported: Decreased hemoglobin

Hepatic

Frequency not reported: Hepatitis, elevated serum transaminases (SGOT, SGPT), bilirubinemia, bilirubinuria, jaundice

Rifampin:

Common (1% to 10%): Elevated alkaline phosphatase

Rare (less than 0.1%): Abnormal liver function, shock-like syndrome with hepatic involvement

Frequency not reported: Hyperbilirubinemia

Hypersensitivity

Rifampin:

Rare (less than 0.1%): Anaphylaxis

Metabolic

Isoniazid:

Frequency not reported: Pellagra, pyridoxine deficiency, metabolic acidosis

Rifampin:

Frequency not reported: Decreased appetite, anorexia

Musculoskeletal

Isoniazid:

Frequency not reported: Systemic lupus erythematosus-like syndrome, rheumatic syndrome

Rifampin:

Rare (less than 0.1%): Myopathy

Frequency not reported: Muscle weakness, bone pain

Nervous system

Peripheral neuropathy associated with isoniazid is dose-dependent, most often occurs in malnourished patients and in patients predisposed to neuritis (such as alcoholics and diabetics), and generally follows paresthesias of the hands and feet. The rate is higher in slow acetylators.

Isoniazid:

Common (1% to 10%): Peripheral neuropathy

Uncommon (0.1% to 1%): Convulsions, toxic encephalopathy, optic neuritis and atrophy, memory impairment

Frequency not reported: Vertigo, polyneuritis (presenting as paresthesia, muscle weakness, loss of tendon reflexes)

Rifampin:

Frequency not reported: Headache, drowsiness, cerebral hemorrhage, ataxia, dizziness, inability to concentrate, muscular weakness, pains in extremities, generalized numbness

Ocular

Rifampin:

Frequency not reported: Tear discoloration, visual disturbances, conjunctivitis

Other

Frequency not reported: Fever

Isoniazid:

Frequency not reported: Anti-nuclear antibodies

Rifampin:

Frequency not reported: Influenza-like syndrome, post-partum hemorrhage, fetal-maternal hemorrhage, porphyria, edema, fatigue, facial edema, edema of the extremities, shock

Psychiatric

Isoniazid:

Frequency not reported: Toxic psychosis

Rifampin:

Frequency not reported: Psychotic disorder/psychoses, mental confusion, behavioral changes

Renal

Rifampin:

Rare (less than 0.1%): Hemolysis, hemoglobinuria, hematuria, interstitial nephritis, acute tubular necrosis, renal insufficiency, acute renal failure

Frequency not reported: Acute kidney injury, chromaturia, increased blood creatinine, elevated BUN, elevated serum uric acid

Respiratory

Rifampin:

Frequency not reported: Dyspnea, wheezing, discolored sputum, shortness of breath

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Rifamate